Suppr超能文献

朊蛋白(106 - 126)在生理条件下不与细胞膜相互作用。

PrP(106-126) does not interact with membranes under physiological conditions.

作者信息

Henriques Sónia Troeira, Pattenden Leonard Keith, Aguilar Marie-Isabel, Castanho Miguel A R B

机构信息

Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.

出版信息

Biophys J. 2008 Aug;95(4):1877-89. doi: 10.1529/biophysj.108.131458. Epub 2008 May 9.

Abstract

Transmissible spongiform encephalopathies are neurodegenerative diseases characterized by the accumulation of an abnormal isoform of the prion protein PrP(Sc). Its fragment 106-126 has been reported to maintain most of the pathological features of PrP(Sc), and a role in neurodegeneration has been proposed based on the modulation of membrane properties and channel formation. The ability of PrP(Sc) to modulate membranes and/or form channels in membranes has not been clearly demonstrated; however, if these processes are important, peptide-membrane interactions would be a key feature in the toxicity of PrP(Sc). In this work, the interaction of PrP(106-126) with model membranes comprising typical lipid identities, as well as more specialized lipids such as phosphatidylserine and GM1 ganglioside, was examined using surface plasmon resonance and fluorescence methodologies. This comprehensive study examines different parameters relevant to characterization of peptide-membrane interactions, including membrane charge, viscosity, lipid composition, pH, and ionic strength. We report that PrP(106-126) has a low affinity for lipid membranes under physiological conditions without evidence of membrane disturbances. Membrane insertion and leakage occur only under conditions in which strong electrostatic interactions operate. These results support the hypothesis that the physiological prion protein PrP(C) mediates PrP(106-126) toxic effects in neuronal cells.

摘要

传染性海绵状脑病是一类神经退行性疾病,其特征是异常形式的朊病毒蛋白PrP(Sc)的积累。据报道,其106 - 126片段保留了PrP(Sc)的大部分病理特征,并且基于对膜特性和通道形成的调节作用,有人提出该片段在神经退行性变中发挥作用。PrP(Sc)调节膜和/或在膜中形成通道的能力尚未得到明确证实;然而,如果这些过程很重要,那么肽 - 膜相互作用将是PrP(Sc)毒性的一个关键特征。在这项工作中,使用表面等离子体共振和荧光方法研究了PrP(106 - 126)与包含典型脂质种类以及更特殊脂质(如磷脂酰丝氨酸和GM1神经节苷脂)的模型膜之间的相互作用。这项全面的研究考察了与肽 - 膜相互作用表征相关的不同参数,包括膜电荷、粘度、脂质组成、pH值和离子强度。我们报告称,在生理条件下,PrP(106 - 126)对脂质膜的亲和力较低,且没有膜扰动的迹象。只有在强静电相互作用起作用的条件下才会发生膜插入和泄漏。这些结果支持了生理朊病毒蛋白PrP(C)介导PrP(106 - 126)对神经元细胞毒性作用的假说。

相似文献

1
PrP(106-126) does not interact with membranes under physiological conditions.
Biophys J. 2008 Aug;95(4):1877-89. doi: 10.1529/biophysj.108.131458. Epub 2008 May 9.
2
The role of prion peptide structure and aggregation in toxicity and membrane binding.
J Neurochem. 2000 Dec;75(6):2536-45. doi: 10.1046/j.1471-4159.2000.0752536.x.
5
Copper modulation of ion channels of PrP[106-126] mutant prion peptide fragments.
J Membr Biol. 2003 May 1;193(1):35-45. doi: 10.1007/s00232-002-2005-5.
6
Is PrP(106-126) fragment involved in the membrane activity of the Prion protein?
Curr Protein Pept Sci. 2010 Aug;11(5):326-33. doi: 10.2174/138920310791330604.
7
Synthesis and structural characterization of a mimetic membrane-anchored prion protein.
FEBS J. 2006 Mar;273(6):1285-99. doi: 10.1111/j.1742-4658.2006.05152.x.
8
A C-terminal membrane anchor affects the interactions of prion proteins with lipid membranes.
J Biol Chem. 2014 Oct 24;289(43):30144-60. doi: 10.1074/jbc.M114.587345. Epub 2014 Sep 12.
10
Effect of phospholipid liposomes on prion fragment (106-128) amyloid formation.
Biochim Biophys Acta Biomembr. 2023 Oct;1865(7):184199. doi: 10.1016/j.bbamem.2023.184199. Epub 2023 Jul 16.

引用本文的文献

1
The Effects of Metal Ions on the Cytotoxicity and Selectivity of a Histidine-Containing Lytic Peptide.
Int J Pept Res Ther. 2013 Sep;19(3):239-244. doi: 10.1007/s10989-013-9344-1. Epub 2013 Feb 24.
2
Modified horseshoe crab peptides target and kill bacteria inside host cells.
Cell Mol Life Sci. 2021 Dec 31;79(1):38. doi: 10.1007/s00018-021-04041-z.
3
The pH-sensitive action of cholesterol-conjugated peptide inhibitors of influenza virus.
Biochim Biophys Acta Biomembr. 2021 Dec 1;1863(12):183762. doi: 10.1016/j.bbamem.2021.183762. Epub 2021 Sep 1.
4
Discovery and mechanistic studies of cytotoxic cyclotides from the medicinal herb .
J Biol Chem. 2020 Aug 7;295(32):10911-10925. doi: 10.1074/jbc.RA120.012627. Epub 2020 May 15.
6
PHAB toxins: a unique family of predatory sea anemone toxins evolving via intra-gene concerted evolution defines a new peptide fold.
Cell Mol Life Sci. 2018 Dec;75(24):4511-4524. doi: 10.1007/s00018-018-2897-6. Epub 2018 Aug 14.
7
Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria.
Cell Chem Biol. 2018 Apr 19;25(4):380-391.e5. doi: 10.1016/j.chembiol.2018.01.005. Epub 2018 Feb 3.

本文引用的文献

1
GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes.
J Am Chem Soc. 2007 May 9;129(18):5954-61. doi: 10.1021/ja069375w. Epub 2007 Apr 13.
3
Study on the binding of Thioflavin T to beta-sheet-rich and non-beta-sheet cavities.
J Struct Biol. 2007 Jun;158(3):358-69. doi: 10.1016/j.jsb.2006.12.010. Epub 2006 Dec 31.
4
Ganglioside G(M1)-mediated amyloid-beta fibrillogenesis and membrane disruption.
Biochemistry. 2007 Feb 20;46(7):1913-24. doi: 10.1021/bi062177x. Epub 2007 Jan 26.
5
Cell-penetrating peptides and antimicrobial peptides: how different are they?
Biochem J. 2006 Oct 1;399(1):1-7. doi: 10.1042/BJ20061100.
6
N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis.
Biochem Biophys Res Commun. 2006 Sep 22;348(2):379-85. doi: 10.1016/j.bbrc.2006.07.065. Epub 2006 Jul 24.
7
Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells.
J Biol Chem. 2006 Sep 22;281(38):28470-9. doi: 10.1074/jbc.M602774200. Epub 2006 Jul 24.
8
An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
Neurobiol Dis. 2006 Sep;23(3):669-78. doi: 10.1016/j.nbd.2006.05.011. Epub 2006 Jul 17.
9
The role of rafts in the fibrillization and aggregation of prions.
Chem Phys Lipids. 2006 Jun;141(1-2):66-71. doi: 10.1016/j.chemphyslip.2006.02.022. Epub 2006 Mar 27.
10
Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions.
Biochim Biophys Acta. 2006 Jan;1760(1):55-61. doi: 10.1016/j.bbagen.2005.10.001. Epub 2005 Oct 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验